Comparison between the effect of Rosuvastatin and Orlept (Sodium Valproate) in Decrease of migraine headaches
Not Applicable
Recruiting
- Conditions
- Migraine headaches.Migraine
- Registration Number
- IRCT20180114038369N1
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Those who have not received sodium valproate within the last six month.
Have migraine headaches With or Without a up to 6 month before this study
Confirmation of the presence of migraine by the neurologist
There are more than 4 month of attack
Have two or more headache attacks over the past 3 month
Exclusion Criteria
Patients with mental illness
Patients with systemic and background diseases such as diabetes, liver or malignant diseases
Pregnant and Lactating women
Desire to quit of this study
See incidence of complications
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Migraine headache. Timepoint: Follow up these Patient will be done for 3 months. Method of measurement: The severity of migraine headache is measured by the Visual Analogue Scale (VAS).
- Secondary Outcome Measures
Name Time Method